Interleukin-22-producing innate immune cells: New players in mucosal immunity and tissue repair?

Nature Reviews Immunology

Volumn 9, Issue 4, 2009, Pages 229-234

  Vivier, Eric ^a,b   Spits, Hergen ^c   Cupedo, Tom ^d  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c GENENTECH INC   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 22; PROTEIN P46; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RORC; UNCLASSIFIED DRUG;

CELL ISOLATION; CYTOKINE PRODUCTION; HUMAN; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; LYMPH NODE CELL; MUCOSAL IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE SUBPOPULATION; TISSUE REPAIR; TONSIL CELL;

ANIMALS; CELL LINEAGE; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INTERLEUKINS; INTESTINAL MUCOSA; KILLER CELLS, NATURAL; LYMPHOCYTES; LYMPHOID PROGENITOR CELLS; MICE; MODELS, BIOLOGICAL; PALATINE TONSIL; REGENERATION;

EID: 63149153344     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2522     Document Type: Review

References (47)

1. Mebius, R. E. Organogenesis of lymphoid tissues. Nature Rev. Immunol. 3, 292-303 (2003).
2. + cells that can differentiate to APC, NK cells and follicular cells but not T or B cells. Immunity 7, 493-504 (1997).
3. Sun, Z. et al. Requirement for RORγ in thymocyte survival and lymphoid organ development. Science 288, 2369-2373 (2000).
4. Eberl, G. et al. An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells. Nature Immunol. 5, 64-73 (2004).
5. Yokota, Y. et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397, 702-706 (1999).
6. + lympho-hemopoietic progenitors develop. J. Exp. Med. 184, 1449-1459 (1996).
7. Naito, T., Shiohara, T., Hibi, T., Suematsu, M. & Ishikawa, H. RORγt is dispensable for the development of intestinal mucosal T cells. Mucosal Immunol. 1, 198-207 (2008).
8. Yoshida, H. et al. Expression of α4β7 integrin defines a distinct pathway of lymphoid progenitors committed to T cells, fetal intestinal lymphotoxin producer, NK, and dendritic cells. J. Immunol. 167, 2511-2521 (2001).
9. Cupedo, T. et al. Presumptive lymph node organizers are differentially represented in developing mesenteric and peripheral nodes. J. Immunol. 173, 2968-2975 (2004).
10. Tsuji, M. et al. Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity 29, 261-271 (2008).
11. Kim, M. Y. et al. Heterogeneity of lymphoid tissue inducer cell populations present in embryonic and adult mouse lymphoid tissues. Immunology 124, 166-174 (2008).
12. Takatori, H. et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 206, 35-41 (2009).
13. Scandella, E. et al. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nature Immunol. 9, 667-675 (2008).
14. + natural killer-like cells. Nature Immunol. 10, 66-74 (2009).
15. + T helper cells. Cell 126, 1121-1133 (2006).
16. H17 cells in development: an updated view of their molecular identity and genetic programming. Nature Rev. Immunol. 8, 337-348 (2008).
17. Ivanov, I. I. et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4, 337-349 (2008).
18. Ouyang, W., Kolls, J. K. & Zheng, Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28, 454-467 (2008).
19. + cell populations in gut and skin. Nature Immunol. 10, 75-82 (2009).
20. + cells. Nature Immunol. 10, 83-91 (2009).
21. Cella, M. et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722-725 (2009).
22. + cells that provide innate mucosal immune defense. Immunity 29, 958-970 (2008).
23. Moretta, A., Biassoni, R., Bottino, C., Mingari, M. C. & Moretta, L. Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. Immunol. Today 21, 228-234 (2000).
24. Moretta, L. & Moretta, A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. Embo J. 23, 255-259 (2004).
25. Mandelboim, O. et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409, 1055-1060 (2001).
26. + to post-genomics meta-analyses. Curr. Opin. Immunol. 19, 365-372 (2007).
27. Walzer, T. et al. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc. Natl Acad. Sci. USA 104, 3384-3389 (2007).
28. Meresse, B. et al. Reprogramming of CTLs into natural killer-like cells in celiac disease. J. Exp. Med. 203, 1343-1355 (2006).
29. Vivier, E. & Anfossi, N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nature Rev. Immunol. 4, 190-198 (2004).
30. Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N. & Raulet, D. H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nature Immunol. 1, 119-126 (2000).
31. Jamieson, A. M. et al. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17, 19-29 (2002).
32. Groh, V. et al. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl Acad. Sci. USA 93, 12445-12450 (1996).
33. Diefenbach, A., Jensen, E. R., Jamieson, A. M. & Raulet, D. H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413, 165-171 (2001).
34. Gasser, S., Orsulic, S., Brown, E. J. & Raulet, D. H. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436, 1186-1190 (2005).
35. Vivier, E., Tomasello, E., Baratin, M., Walzer, T. & Ugolini, S. Functions of natural killer cells. Nature Immunol. 9, 503-510 (2008).
36. Zenewicz, L. A. et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29, 947-957 (2008).
37. Casamayor-Palleja, M. et al. Expression of macrophage inflammatory protein-3α, stromal cell-derived factor-1, and B-cell-attracting chemokine-1 identifies the tonsil crypt as an attractive site for B cells. Blood 97, 3992-3994 (2001).
38. Kwon, J. H., Keates, S., Bassani, L., Mayer, L. F. & Keates, A. C. Colonic epithelial cells are a major site of macrophage inflammatory protein 3α (MIP-3α) production in normal colon and inflammatory bowel disease. Gut 51, 818-826 (2002).
39. Tanaka, Y. et al. Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans. Eur. J. Immunol. 29, 633-642 (1999).
40. Coles, M. C. et al. Role of T and NK cells and IL7/IL7R interactions during neonatal maturation of lymph nodes. Proc. Natl Acad. Sci. USA 103, 13457-13462 (2006).
41. Freud, A. G. et al. Evidence for discrete stages of human natural killer cell differentiation in vivo. J. Exp. Med. 203, 1033-1043 (2006).
42. Quong, M. W., Romanow, W. J. & Murre, C. E protein function in lymphocyte development. Annu. Rev. Immunol. 20, 301-322 (2002).
43. Boos, M. D., Yokota, Y., Eberl, G. & Kee, B. L. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J. Exp. Med. 204, 1119-1130 (2007).
44. Kennedy, M. K. et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin-15-deficient mice. J. Exp. Med. 191, 771-780 (2000).
45. - cells in the embryonic intestine induces the organizing center of Peyer's patches. Int. Immunol. 11, 643-655 (1999).
46. Malmberg, K. J. & Ljunggren, H. G. Spotlight on IL-22-producing NK cell receptor-expressing mucosal lymphocytes. Nature Immunol. 10, 11-12 (2009).
47. H17 cytokine interleukin-22. Blood 24 Feb 2009 (doi:10.1182/blood-2008-12-19244).